Literature DB >> 36169867

Computational Chemistry and Molecular Modeling of Reversible MAO Inhibitors.

Kemal Yelekçi1, Safiye Sağ Erdem2.   

Abstract

Proper elucidation of drug-target interaction is one of the most significant steps at the early stages of the drug development research. Computer-aided drug design tools have substantial contribution to this stage. In this chapter, we specifically concentrate on the computational methods widely used to develop reversible inhibitors for monoamine oxidase (MAO) isozymes. In this context, current computational techniques in identifying the best drug candidates showing high potency are discussed. The protocols of structure-based drug design methodologies, namely, molecular docking, in silico screening, and molecular dynamics simulations, are presented. Employing case studies of safinamide binding to MAO B, we demonstrate how to use AutoDock 4.2.6 and NAMD software packages.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Docking; Molecular dynamics; Monoamine oxidase; Virtual screening

Mesh:

Substances:

Year:  2023        PMID: 36169867     DOI: 10.1007/978-1-0716-2643-6_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  63 in total

1.  Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.

Authors:  Claudia Binda; Paige Newton-Vinson; Frantisek Hubálek; Dale E Edmondson; Andrea Mattevi
Journal:  Nat Struct Biol       Date:  2002-01

2.  Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor.

Authors:  Matic Pavlin; Janez Mavri; Matej Repič; Robert Vianello
Journal:  J Neural Transm (Vienna)       Date:  2013-04-02       Impact factor: 3.575

3.  cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.

Authors:  Thomas Malcomson; Kemal Yelekci; Maria Teresa Borrello; A Ganesan; Elena Semina; Norbert De Kimpe; Sven Mangelinckx; Rona R Ramsay
Journal:  FEBS J       Date:  2015-03-27       Impact factor: 5.542

Review 4.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

5.  Mechanism-based enzyme inactivators.

Authors:  R B Silverman
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.

Authors:  Luigi De Colibus; Min Li; Claudia Binda; Ariel Lustig; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

7.  Quantum chemical modeling of the inhibition mechanism of monoamine oxidase by oxazolidinone and analogous heterocyclic compounds.

Authors:  Safiye Sağ Erdem; Gül Altınbaş Özpınar; Ümüt Boz
Journal:  J Enzyme Inhib Med Chem       Date:  2013-01-17       Impact factor: 5.051

8.  Effect of the locus of the oxygen atom in amino ethers on the inactivation of monoamine oxidase B.

Authors:  K Yelekçi; R B Silverman
Journal:  J Enzyme Inhib       Date:  1998-02

9.  The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.

Authors:  C J Fowler; T J Mantle; K F Tipton
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

10.  Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.

Authors:  Frantisek Hubálek; Claudia Binda; Min Li; Yaacov Herzig; Jeffrey Sterling; Moussa B H Youdim; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.